It was also found that IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wild-type cells to venetoclax, which was due to mitochondrial electron transport chain alterations that lowered the threshold of apoptosis induced by this BCL-2 antagonist [111]. This evidence concerns the gene BCL2 and acute myeloid leukemia.